Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Neoplasm, Residual × Hydroxychloroquine × Clear all

Sponsor

Conditions

Pancreatic Neoplasms 5 Prostatic Neoplasms 4 Carcinoma, Non-Small-Cell Lung 4 Neoplasms 3 Colorectal Neoplasms 3 Gastrointestinal Neoplasms 2 Sarcoma 1 Rectal Neoplasms 1 Pancreatic Cancer Resectable 1 Lymphangioleiomyomatosis 1 Lung Neoplasms 1 Gliosarcoma 1 Glioblastoma 1 Colonic Neoplasms 1 Cholangiocarcinoma 1 Central Nervous System Neoplasms 1 Carcinoma, Renal Cell 1 COVID-19 1 Breast Neoplasms, Male 1 Breast Neoplasms 1 Biliary Tract Neoplasms 1 Bile Duct Neoplasms 1 Arthritis, Rheumatoid 1 Anatomic Stage I Breast Cancer AJCC v8 1 Adenocarcinoma of Lung 1

Interventions

Rituximab 4 blinatumomab 3 Whole-Body Irradiation 2 Lenalidomide 2 Cyclophosphamide 2 Clofarabine 2 treosulfan 1 thymoglobulin 1 sabatolimab 1 peginterferon alfa-2a 1 obinutuzumab 1 midostaurin 1 ixazomib 1 fludarabine phosphate 1 fludarabine 1 eribulin 1 daratumumab 1 acalabrutinib 1 Trastuzumab 1 Tacrolimus 1 Sodium Chloride 1 Peripheral Blood Stem Cell Transplantation 1 Pentostatin 1 N,N-dicyclohexyl-isoborneol-10-sulfonamide 1 Mycophenolic Acid 1 Methotrexate 1 Melphalan 1 Magnetic Resonance Imaging 1 Imatinib Mesylate 1 Histamine Antagonists 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡